Related Experiment Video

Updated: Aug 8, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Does BCG have a role in tuberculosis control and prevention in the United Kingdom?

S S S Teo1, D V Shingadia

  • 1Centre for Child Health, Institute of Community Health Sciences, Barts and the London Queen Mary's School of Medicine and Dentistry, University of London, London, UK.

Archives of Disease in Childhood
|May 23, 2006
PubMed

Insights

The UK updated its BCG vaccination policy for children due to evolving tuberculosis (TB) epidemiology. School programs were stopped, and high-risk infants and children are now targeted for TB prevention.

Area of Science:

  • Pediatric infectious diseases
  • Public health policy
  • Immunology

Background:

  • The United Kingdom has revised its Bacillus Calmette-Guérin (BCG) vaccination strategy for children.
  • This policy shift addresses the changing landscape of tuberculosis (TB) epidemiology within the pediatric population.
  • The previous widespread school-based BCG program has been discontinued due to a low perceived risk in that demographic.

Purpose of the Study:

  • To analyze the recent changes in the UK's BCG vaccination policy for children.
  • To understand the rationale behind shifting from a universal school program to targeted infant and child vaccination.
  • To explore the ongoing uncertainties regarding the role of BCG in pediatric tuberculosis control and prevention in the UK.

Main Methods:

  • Policy analysis of the updated UK BCG vaccination guidelines.
  • Epidemiological review of childhood tuberculosis trends in the UK.
  • Literature review on the efficacy and role of BCG in TB prevention, particularly in at-risk populations.

Main Results:

  • The UK has ceased its long-standing school-based BCG vaccination program.
  • Vaccination efforts are now focused on infants and children identified as being at increased risk of TB.
  • Particular emphasis is placed on targeting populations that exhibit higher rates of tuberculosis.

Conclusions:

  • The UK's BCG policy modification reflects a strategic response to current TB epidemiology in children.
  • The move away from universal school programs towards targeted vaccination aims to optimize resource allocation and impact.
  • Further evaluation is needed to clarify the precise role and effectiveness of BCG in contemporary UK tuberculosis control strategies.

More Related Videos

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...